Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples